The pathogenesis of ME/CFS, a disease characterized by fatigue, cognitive dysfunction, sleep disturbances, orthostatic intolerance, fever, irritable bowel syndrome (IBS), and lymphadenopathy, is poorly understood. We report biomarker discovery and topological analysis of plasma metabolomic, fecal bacterial metagenomic, and clinical data from 50 ME/CFS patients and 50 healthy controls. We confirm reports of altered plasma levels of choline, carnitine and complex lipid metabolites and demonstrate that patients with ME/CFS and IBS have increased plasma levels of ceramide. Integration of fecal metagenomic and plasma metabolomic data resulted in a stronger predictive model of ME/CFS (cross-validated AUC = 0.836) than either metagenomic (cross-validated AUC = 0.745) or metabolomic (cross-validated AUC = 0.820) analysis alone. Our findings may provide insights into the pathogenesis of ME/CFS and its subtypes and suggest pathways for the development of diagnostic and therapeutic strategies.
Insights into M.E: The pathogenesis of ME... - Ramsays Disease
Insights into M.E
Written by
Ian123
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
More evidence something out of whack just no smoking gun on cause
Not what you're looking for?
You may also like...
M.E Petition
The NHS provides psychiatric therapies for what it refers to as "CFS/ME". These therapies are often...
Low Blood Volume
Dr David Streeten discovered while treating patients for orthostatic intolerance that one had a low...
Cognitive Dysfunction
Scientists Find Clues Into Cognitive Dysfunction in Chronic Fatigue Syndrome...
Post Exertional Malaise
Post-exertional malaise a defining, compulsory and cardinal feature for diagnosis under most...
Vitamin B12
Response to Vitamin B12 and Folic Acid in Myalgic Encephalomyelitis and Fibromyalgia
Björn...